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ABSTRACT 
AIm: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established therapy for patients with Parkinson’s disease (PD) 
associated with motor complications of long term L-dopa treatment.
mAterIAl and methOds: Here we report two cases with DBS- induced manic episode, focusing on the functional and anatomic correlates 
of psychiatric adverse effects of STN stimulation.     
results: We present two cases of PD with motor complications due to long term L-dopa treatment that developed their first episodes of 
mania with psychotic symptoms after bilateral STN-DBS implantation. DBS-induced psychiatric adverse effects may be attributable either to 
limbic connections and STN-specific oscillations or stimulation of the medial forebrain bundle.      
KeywOrds: Deep brain stimulation, Subthalamic nucleus, Mania, Parkinson’s disease 
ÖZ 
AmAÇ: Subtalamik nükleusun (STN) derin beyin stimülasyonu (DBS), uzun süreli L-dopa tedavisinin motor komplikasyonlarının geliştiği 
Parkinson Hastalığı (PH)’nda uygulanan bir tedavidir.
yÖntem ve GereÇler: Bu yazıda, STN stimülasyonunun psikiyatrik yan etkilerinin anatomik ve fonksiyonel bağlantıları üzerinde durularak, 
DBS sonrasında manik atak gelişen iki olgunun sunulması amaçlandı.      
BulGulAr: Uzun süreli L-dopa tedavisine bağlı motor komplikasyonları olan ve STN-DBS uygulaması sonrası ilk psikotik belirtili manik atağı 
ortaya çıkan iki PD olgusunu sunduk. DBS ilişkili psikiyatrik yan etkiler ya limbik bağlantılara ve STN spesifik osilasyonlara ya da medyal ön 
beyin demetinin uyarılmasına bağlı olabilir.       
AnAhtAr sÖZCÜKler: Derin beyin stimülasyonu, Subtalamik nükleus, Mani, Parkinson hastalığı
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Manic Episode Following Deep Brain Stimulation 
of  the Subthalamic Nucleus for parkinson’s Disease:         
A Case Report 
Parkinson Hastalığında Subtalamik Nükleusun Derin Beyin 
Stimülasyonu Sonrası Gelişen Manik Atak: Bir Olgu Sunumu
InTRoduCTIon
Parkinson’s disease (PD) is a progressive neurodegenerative 
disorder characterized by bradykinesia, resting tremor, rigidity 
and postural instability. Psychiatric symptoms can ocur in 
61% of the patients either due to disease itself or medication 
adverse effects. In 30-40% of patients have depression and 
30% have psychosis related to seratonergic and dopaminergic 
deficits in the mesolimbic and mesocortical Networks (20).
Over the last two decades surgical therapies became the 
second most important therapeutic application after L-dopa 
and dopamine agonists. Deep brain stimulation (DBS) of the 
subthalamic nucleus (STN) is one of the major targets for 
relieving severe tremor or motor complications of long term 
L-dopa therapy. High frequency stimulation of STN in severely 
disabled patients due to motor complications of dopaminergic 
treatment is associated with a marked improvement in the 
quality of life measures (6, 1). However, it has been reported 
that a wide spectrum of behavioral change and psychiatric 
adverse effects occur as high as 41% for cognitive deficits, 8 % 
for depression, 4% for acute hypomania (16, 17).
Here we report two cases of patients who developed manic 
episodes in the early postoperative period following bilateral 
STN-DBS.
CASe 1
A 56-year-old woman with a 12 year history of PD had been 
treated with L-dopa. Although relieving her bilateral resting 
tremor, bradykinesia, the best management of her treatment 
did not succeed in decreasing the motor complications of the 
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dopaminergic therapy. She had bilateral rigidity, resting tremor 
predominating on the left side of her body. Unified Parkinson’s 
Disease Rating Scale (UPDRS) motor score was 33 “off 
medication” and reduced to 12 “on medication” accompanied 
by severe dyskinesia in four limbs. Her psychiatric evaluation 
revealed exacerbating and remitting depressive episodes 
that were responsive to 20mg/d citalopram treatment. 
During the last month she reported increased depressive 
mood, insomnia and anhedonia. Hamilton Depression Scale 
score was 18 and 10mg/d escitalopram was recommended in 
the postoperative period.
Quadripolar electrodes (Medtronic 37601 activa PC) were 
implanted bilaterally with stereotactic methods as described 
elsewhere (7). On postoperative day 7 (5th day of escitalopram 
treatment) she developed inappropriate behaviors such as 
running in the hall, singing out loud and undressing. Her 
postoperative psychiatric evaluation revealed increased and 
rapid speech, racing thoughts, disjointed thinking, euphoria, 
grandiosity, persecutive hallucinations, religious activities, 
increased libido, psychomotor activity, insomnia, deterioration 
of reality assessment and judgment and lack of insight. Young 
Mania Scoring Scale (YMSS) was 38 and diagnosed as manic 
episode with psychotic symptoms, eventually put on 10mg/d 
olanzapine and escitalopram was ceased. In follow-up 
psychiatric evaluation after one month she had none of the 
previous manic symptoms and YMSS was 0. Olanzapine was 
tapered down and ceased. In her neurological examination 
UPDRS score was 10 “on stimulation” and “on medication” and 
severe dyskinesias disappeared. After her second follow-up 
visit she was put on 10mg/d escitalopram because of anxiety, 
decreased libido and increased appetite. Ten months after 
STN-DBS implantation she was euthymic and had no manic 
symptoms.
CASe 2
A 57-year-old man with a 10-year history of unilateral tremor 
and bradykinesia was admitted to neurosurgery clinic for STN-
DBS implantation because of severe motor complications 
of L-dopa treatment. His neurological examination revealed 
bilateral resting tremor and bradykinesia predominating 
on the left side of his body. Motor score of UPDRS was 30 
“off” medication. In his preoperative psychiatric evaluation 
there was no active psychopathology. Bilateral STN-DBS 
implantation was carried out as described above. In the third 
postoperative day he was re-evaluated because of elevated 
mood, increased speech, hyperactivity and spending sprees. 
His psychiatric evaluation revealed increased and rapid 
speech, racing thoughts, disjointed thinking and euphoria. 
YMSS was 26 and was put on 1mg/d haloperidol, tapered 
to 2mg/d. During the following weeks his manic symptoms 
subsided and YMSS was 0. Motor scores of UPDRS reduced 
to 7 “on stimulation” and “on medication” and peak-dose 
dyskinesias disappeared. During his follow-up visit for 
increased tremor and bradykinesia stimulation intensity 
was increased. Approximately 24 hours following the new 
parameter settings (bipolar 3.5 V 90μsec, 180 Hz) he developed 
an abrupt manic reaction which gradually subsided in 3 days 
after switching to more dorsal electrode contacts.
dISCuSSIon
We present two cases of PD with motor complications due 
to long term L-dopa treatment that developed their first 
episodes of mania with psychotic symptoms after bilateral 
STN-DBS implantation. Several authors have reported a wide 
spectrum of psychiatric alterations after STN-DBS, such as 
depression, manic episode and anxiety (19, 18, 13, 8, 2, 15, 
21). A decompensation of preexisting psychiatric disorders 
such as depression and anxiety disorders can be induced by 
STN-DBS. Krack and colleagues reported a case with mirthful 
laughter when stimulated with supramaximal parameters (9). 
Besides, hypomania/mania has also been reported by many 
authors (19, 18, 13, 8). Romito and associates described 2 
patients with transient mania associated with hypersexuality 
appeared in several days after initiation of STN stimulation. 
In these cases stimulation arrest did not acutely influence 
manic symptoms (14). Our first case STN-DBS related mania 
appeared on postoperative day 7 and continued for 1 month 
and gradually subsided with medical treatment. We think that 
her underlying affective disorder may be a predisposing factor 
for her DBS induced mania. In another report a reversible 
manic behavior was related to stimulation of contacts 
misplaced to caudal STN in the midbrain level and the manic 
behavior disappeared after stimulation of a different contact 
located in the level of STN. Thus, the authors concluded that 
manic disorders might be caused by affection of structures 
in the ventral midbrain (10). Similarly, Raucher-Chene and 
colleagues (13) reported a patient with manic episodes due 
to STN-DBS who responded to the change in stimulation 
target. They suggested that medial part of the STN play a key 
role in the occurrence of manic symptoms. However, Herzog 
and associates (8) suggested that stimulation of the STN, but 
not the adjacent structures resulted in manic psychosis. In 
their report bilateral monopolar stimulation of STN resulted 
in hypomanic state which progressed to a manic episode 
with psychotic symptoms in 3 weeks. Stimulation arrest 
was intolerable because of immediate worsening of motor 
symptoms. The patient has been put on 150mg/d clozapine 
which alleviated the psychotic symptoms. However, mixed 
features both with mania and depression at the same time 
led to the diagnosis of organic bipolar disorder which is 
attributed to stimulation of STN but not adjacent structures. 
There is a similarity between hypomania in bipolar disorder 
and DBS-induced hypomania. In DBS-induced hypomania 
patients often report that they feel possessed (8, 14). They 
are overactive without signs of exhaustion. They engage in 
individually specific but overlapping risk-taking activities 
such as hypersexuality, gambling and money spending. Many 
authors had suggestions on the anatomic and functional 
correlates of these symptoms with STN stimulation. In our 
second case, manic symptoms appeared on postoperative 
day 3 and continued for a few weeks. He also reported 
hyperactivity and spending like in cases previously reported 
(8, 14). We think that, the stimulation of caudal STN has an 
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important influence on the appearance of manic symptoms, 
because an abrupt manic reaction occurred which gradually 
subsided in 3 days after switching to more dorsal electrode 
contacts.
The STN has an anatomically central position within the 
basal ganglia-thalamocortical associative and limbic circuits. 
Despite the fact that it is a very small structure, it is a major 
player in the input and output of the basal ganglia motor 
circuitry. The involvement of the STN in motor function 
regulation is obvious and its stimulation has an immediate 
and robust clinical effect on PD. This may be explained by 
its role within the basal gangliathalamocortical circuitry. 
Besides its control on motor activity, the STN is involved in the 
processing of certain cognitive and executive functions and 
modulating motivation (3, 4). These features may be related 
to dopamine dysregulation syndrome, impulse control 
disorders and punding in PD (11). However, the involvement 
of STN in non-motor function is less robust and usually 
temporary. Therefore STN may be an indirect modulator 
of non-motor functions. Most authors postulate that STN 
induced psychiatric adverse effects are a result of diffusion 
of current into the inferior and medial STN, influencing its 
limbic subnucleus and its associated circuitry (17, 10). Recent 
functional neurosurgery has provided the opportunity to 
record directly from the human basal ganglia, most commonly 
in patients with PD undergoing DBS electrode implantation. 
The studies focusing on single unit recordings and local field 
potentials recorded intraoperatively via microelectrodes 
demonstrated that specific oscillations in the STN are involved 
in decisional processes, cognitive functions, emotion control 
and conflict that could explain the post-DBS occurrence of 
behavioral disturbances (12). However in a single report acute 
hypomania induced during STN-DBS attributed to activation 
of medial forebrain bundle which is a structure of the reward 
circuitry and a key structure of mesolimbic-dopamine system 
that is related to affective disorders, drug addiction and 
learning (5).
In conclusion, DBS-induced psychiatric adverse effects may 
be attributable either to limbic connections and STN-specific 
oscillations or stimulation of the medial forebrain bundle. 
The exact role of the STN and the basal ganglia in non-motor 
functions remains an important and interesting challenge for 
future research.
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